Drug Shortage Report for THYMOGLOBULIN
Report ID | 73721 |
Drug Identification Number | 02246805 |
Brand name | THYMOGLOBULIN |
Common or Proper name | Thymoglobulin |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ANTI-THYMOCYTE GLOBULIN |
Strength(s) | 25MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 1 X 10ml |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-04-01 |
Actual start date | |
Estimated end date | 2019-04-15 |
Actual end date | 2019-03-20 |
Shortage status | Avoided shortage |
Updated date | 2019-03-22 |
Company comments | Delay in Supply (Potential Back Order) - All efforts are being made to resolve these issues and avoid an out of stock situation. As a result, we will be allocating purchasing of Thymoglobulin based on each accounts historical sales data. Any updates will be communicated on the www.drugshortagescanada.ca website. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-28 | English | Compare |
v2 | 2019-01-28 | French | Compare |
v3 | 2019-01-29 | English | Compare |
v4 | 2019-01-29 | French | Compare |
v5 | 2019-01-29 | English | Compare |
v6 | 2019-01-29 | French | Compare |
v7 | 2019-03-22 | English | Compare |
v8 | 2019-03-22 | French | Compare |
Showing 1 to 8 of 8